news

  • 4 April 2019
    Sequana Medical announces 2018 Full Year Results and 2019 Outlook

    Sequana Medical NV (Euronext Brussels: SEQUA), a commercial stage medical device company focused on innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders, today announces its business highlights and financial results for the year ended 31 December 2018, prepared in accordance with IFRS as endorsed by the European Union, as well as post-period highlights and an outlook for the remainder of the year.

    Download the full press release